Google TrendPOSICIONES DE ATLÉTICO DE MADRID CONTRA MANCHESTER UNITED (5000+) — Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Cardiometabolic and molec" (30 stories)

Top Headline Story

Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial
Lead StoryNaturegeneral
Dec 13, 2025

Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5hTGd2UmcxNEhuaUd6amVmckFMX0hyaW0ta2RtcVI2anVkcDRmRlVQeWppWmE1OVh5YkQ1b2RMaVMxb3VuUWJkclJRRHBoLVJXMU9TZTJfMlpHWjlvZmdN?oc=5" target="_blank">Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
5000+22m ago

posiciones de atlético de madrid contra manchester united

Atlético 2 - 0 Manchester United: resumen, goles y resultado de la Champions League

2000+22m ago

devils vs red wings

Devils at Red Wings projected lineups

5000+22m ago

lioness season 3

Thank Zoe Saldaña for ‘Lioness’ Season 3’s Perfect Cliff-Hanger

200+32m ago

luis díaz

Max Eberl knows Luis Díaz will start scoring again for Bayern Munich

Search Results for "Cardiometabolic and molec"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases
Business Wiregeneral

Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases

<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxPQmtQblhQUWNCa2VBd3JPSC1LNjBfemZHNFVaRmlPN19hZ19PQzJOUHFrYl9mdnlockVoN1d5dEQtOWNGdnRpemhtY0xJbFA3WGJLQXdJSk5PUGxFdXFsREtCaGpUTmhlT29ROUExRGZCWkJaUWR4UDVjQW8yYnRKTlZQcHpaX0R6MjdzT0RUbThESnNSWk5ta1g1VmNMYzdqVnA0b3lVU1JjQ0V3MTBwb2JySW9oY05XY0NLTEkyRzNVY2F3TlNQZ0loVzk2UTNET3FiMnZNNkdFT3V3dXRjMUEzZXZ5YUVUXzd0VkludEtJTjl4cFN2R3FR?oc=5" target="_blank">Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases</a>  <font color="#6f6f6f">Business Wire</font>

Editorial: Molecular biomarkers of cardiometabolic disease - volume II
Frontiersgeneral

Editorial: Molecular biomarkers of cardiometabolic disease - volume II

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxPM2hiNmxEektMcl9UczdYYlhhRU81TTgzc2VGSlBHWWc5M2NEQl9ZeHNhU2ltbUttTi1PLWc0bnpHWHRGeXRJWnBkRklCNlBpYUw0amQ4VG9KVEMwMGxiUFlNUV9xZXRjZWNjSlowUnp4d3laQ1V4aVJmdlQ1S0k4SzlwTjdQaWczY19jMmx4RUxIcS1QS2c?oc=5" target="_blank">Editorial: Molecular biomarkers of cardiometabolic disease - volume II</a>  <font color="#6f6f6f">Frontiers</font>

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio
AstraZenecaworld

Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio

<a href="https://news.google.com/rss/articles/CBMi1gFBVV95cUxQXzktQUdDRjZsbkw0NG1XMEV0NTd3ZVN6RHJNbjdUQjB4UzhaWTFjdFFDZVpGVFpodW5jdTVSeU1vVWdGd25maHV1eEpaT1ZKazBUQmhaNU5XclpZdHp5aXM3a0hJNTR4cTNOeGpQY1hOcVJSd1NmUEJvdlg4bzlqNnp5bEdHSS1xUG1IV3dOMDJvdVZLbjBXblJlOTVtNFl2RXNtRGw4T3ctQXU0NWVudm1OYTlNZWNteVZvX19sT05aUm1BWWdTWHloMzdOZWxfajN0U1pB?oc=5" target="_blank">Elecoglipron, an oral small molecule GLP-1 RA, moves to Phase III programme and unlocks next chapter in AstraZeneca’s cardiometabolic and kidney portfolio</a>  <font color="#6f6f6f">AstraZeneca</font>

Sprint exercise sends a very different molecular signal through the body
News-Medicalgeneral

Sprint exercise sends a very different molecular signal through the body

<a href="https://news.google.com/rss/articles/CBMivAFBVV95cUxNTmNJU2tKSnBabF9QUl9hdTl6eF9mRWozOU11ZHNDaHExaEl2SE5DWTR0Q2hOV2Z4NWtzSnE0Rzk0VHN5UU9nb0RDdzJ5RFpBRGRJU3JNSV9MVzU5MGxjYnlEOElKWk83bDF1QTJ5cHQ0V2NBSkRRemFtRnpUOENudzlPbXNXQXVRRmxrUmZhY0NPd3djaDl3UHl5ejRleFJZdGdVZUtacHNmZExoOHhmUWZ3cXBmSFpFdkYzbQ?oc=5" target="_blank">Sprint exercise sends a very different molecular signal through the body</a>  <font color="#6f6f6f">News-Medical</font>

New Markers of Diabetes and Heart Disease Revealed via Genetic Study in Indians
Inside Precision Medicinegeneral

New Markers of Diabetes and Heart Disease Revealed via Genetic Study in Indians

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxQdjFFZDRaQnhtaXhGeUVZYlhCcjhidVE1OVNKVmh6SnQzUWdlYU5MbEtxNEZTejBVcjRXVTVkRjd2NDZ1Qjkwb0FIeUtENGxocjA1Wld1QXVYd1VfVFpCN1lYZ3NvMkk3NU9kdUlfV2wyRFluNkNPei1vVmx2WjI2UXU3SXRUOFhCMVZDN09iZXBjV3l0bzFLQ3FSellPLWQ2enUxQVFZQzJNemNSRGtoOGdFZEhfY1FfU0FFZENwaHhFVmpQX0xEYzFHcmxCTTJZbUhIalVPNFgtUC1Kb0s0?oc=5" target="_blank">New Markers of Diabetes and Heart Disease Revealed via Genetic Study in Indians</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Ambrosia Biosciences: $100 Million Raised For Cardiometabolic Small Molecule Pipeline Advancement
Pulse 2.0tech

Ambrosia Biosciences: $100 Million Raised For Cardiometabolic Small Molecule Pipeline Advancement

<a href="https://news.google.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?oc=5" target="_blank">Ambrosia Biosciences: $100 Million Raised For Cardiometabolic Small Molecule Pipeline Advancement</a>  <font color="#6f6f6f">Pulse 2.0</font>

Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline
PR Newswirescience

Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline

<a href="https://news.google.com/rss/articles/CBMimAJBVV95cUxOdU55ME1SaU9LWWJmN1luVFBXT2kxT2xBTVpXODRfbUx2VXVlaW5FUnY2d2ZPNEs2SjB1S29JcURZU3J6eXEwOXp3dEQ3bWFiYWNmbDdXUGFrWDFGZjh4by1DX29yUmc1SnlmVzg0X1JTZDBKb1NEVUFMTFhSeFExcTN6VksxWjl4ZHd3QlplMHQ1YnBWeWFleURUdlpQbHhkOXgtS0RnUURUNE83M0IyN0hOQlhpLWREWlRWTjZ3X29ST2RvcnM4SG9ZckhXWGVLTmM2ZGJ6Y0RPX3duRDhjOVIybjNTZkZtU0dmSjNMTVFSdlk2cnFCUUF2aDVGRkVpUEJ1SWJVRXRvclNXWnRPbEM5ZE5XRzQ0?oc=5" target="_blank">Ambrosia Biosciences Announces $100 Million Oversubscribed Series B Financing to Advance Novel Small Molecule Cardiometabolic Pipeline</a>  <font color="#6f6f6f">PR Newswire</font>

Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B
BioSpacegeneral

Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNWGJoS3RSTGh4ZzdnTlQxZ0NwcTN6LURBcjhxVWxndWg5OWttdkN6NGR5bTF0cE5WMWJjQWhITF9Tam9rdXd0UURBMm55aU1xeGdzU2pBVkRLYnFEQTQ4WW5KZkpIVXJ1NWFSQVZNMEx6eDdmLVBLeURfZG5ydVdSa2MxQ2FiWEtDYlJxb2JIVmdTaUNkaTk1TkN4a1ctV2xhbzJkeTRDbw?oc=5" target="_blank">Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B</a>  <font color="#6f6f6f">BioSpace</font>

CORXEL Announces $287 million Series D1 Financing to
GlobeNewswireworld

CORXEL Announces $287 million Series D1 Financing to

<a href="https://news.google.com/rss/articles/CBMiwwJBVV95cUxPM0ZkTm5ZOXRmcFE5ZHprSHlqM3pIdVFyNFlmcjNQQkFiZTB2T2hzRFdjRGo4Tks1N0NGa2pUdE1WSGdKMmFNMUpyT0RLb01RMmV4Y2lZemM2OURic202ZmxTWEhfeVg0RDlSZExZenBqRDVldVhsbnBBcVdPZG1OQVVzVXRMY1FpSHRSLS1QUkVQNnhkUF9zdjdObTZncW9pR0wtbEl0cGhIZjFwWDJNMTNNdXB0X3VleVZWNXBiWXZiNVFLNFNnTHhWcTYzaEtJUHdGM0lYZUU1MWFtRnlfQjNmcGVUMVFTMGJ3YllTNVl5ellubjdtd1pfcFduU3VGQ18zSFNKXzBhTnh1MWVVLXRrQjBadDBxb2tsQU0xMGdqR2hlLURaMk5DMzY5cXAtMDNiMi0tWWw4ZV9yQ3dwM18yMA?oc=5" target="_blank">CORXEL Announces $287 million Series D1 Financing to</a>  <font color="#6f6f6f">GlobeNewswire</font>

Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine
Frontiersgeneral

Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQeDdpQmhjc3lRY0JoZDdzVTQ0Q1dNZ01qNng5M0RZWDBWaWJuNG5sSWRJam9KQUl4emc3ejV6bi0tM2tKRnRxVjl2UzVFelI5UkRsUmJ3MERsSEs1dFJGMGhaUmRTbG5sOEdHeDRJYWRCRkZZRjBReUw5M05idE5uOVhWUFo3bmJvWkVzZzJXdURFdVVv?oc=5" target="_blank">Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine</a>  <font color="#6f6f6f">Frontiers</font>

Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech
Fierce Biotechtech

Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOUmxsdzM0RF9mT1dBUWx5NkZKcDNTQTVlM3dQMGs4M0R6akhwb3c0ZTdLVk9FX0tHQklYaTZmV0EtWUoyOWJMRWVhc2R5eUVLOWE4UWxOeFZ2a3BWOTZpeS0tcW9ybGFwQllhV0hUT3NzYmw4bl84TmRlOG83eUdubHZYeDlhemFROGJQTUVENnBFWnh5cjJ1SFExTnhLeEJIVkotUWZYVGk?oc=5" target="_blank">Zealand pens $2.5B oral cardiometabolic collab with fresh-faced Chinese biotech</a>  <font color="#6f6f6f">Fierce Biotech</font>

Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics
Pharmaceutical Executivepolitics

Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxPbXBPZ2k3d29QSjctMUlrWEJ5RXI4V3lpNlB6TjBTcWcyZ2QtS3kwd1dadEhhSTNLekxtOUI0U3MxUi10NHJVdWlGbTF5MHNyc0ZWT011dHRBbHk5d1N3bVFBVWE3YVVnOFQ1Q2RnbEIxTERFNXpraTNaeEhGMF90Y19Wa1BaYWtPMUpEb1NpaTZZTFdDY3pZS0hlR2o0OVlrTkVSc1JSVHg5V0gxdnhta2FidDNOdw?oc=5" target="_blank">Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics</a>  <font color="#6f6f6f">Pharmaceutical Executive</font>

The controversial role of linoleic acid in cardiometabolic health: from molecular pathways to human studies
Frontiersscience

The controversial role of linoleic acid in cardiometabolic health: from molecular pathways to human studies

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxNQm4zZnczbTFmZGUwbUtiTFpnUHg4WWk1VHdwOFJRSHNQZVFaMXM3b3lGOWJUdkMxOFpubDVQeHE3Q2RLRm50bHdQYXRlUEVZWlo4RjBqV1BlNnc5a3RJZ3d2UzYxdFc2UmV1QWYzdTlMYVNOMkJVMnJndFVhWVA0dDc5aDZ5TmlVRDNXUE5vdw?oc=5" target="_blank">The controversial role of linoleic acid in cardiometabolic health: from molecular pathways to human studies</a>  <font color="#6f6f6f">Frontiers</font>

Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus
Business Wireworld

Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus

<a href="https://news.google.com/rss/articles/CBMirAJBVV95cUxNRnhLMG81VDFuTUxoRWVQVGk5aE96VnNTZ2pLdmNaZVN3Qjg3clJnSkVzTkhaUjZnRTBZQ1dkcENQOGEyaDFuNXZHSGJoNmI3VUhQb19DeTVsLWpqZllNUDQyaW9ld1VIQ0l4dFdHZkpzbmRkU0xtWnY3MmZqeEhuX215dEdqbmxKQ1FsbHVETXE4VzEwQjV2aGltNEdvMm50U0VEUUg1amNIblN3dHBxd2ZRQmNmd2FYdjlCVEhIb0lfWnMtVmVwNWdOYUk5R0gtR1BtYlJ4ZXZLLTJMRXFqcGFIYWZzWVZLdHk2cUo5b2VwblZzdzZkcnZSbHM5amNaMG90aEVtVDZyeGUtNno4RzlpcWNudUZXTk02LWRxUXgyQ3VMelQ4UzFuRXE?oc=5" target="_blank">Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus</a>  <font color="#6f6f6f">Business Wire</font>

Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities
Natureworld

Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1mMHZZeWlCX3JPU0djQjNjVVFMeGRlV293N0NYNjlVUnI2TWw2WkpERDlPY3dtcmVGSm43dlJjM0w0V3dsajNzTF9oOEpLSXpzSlhwckV5SE5SbEIyTlZF?oc=5" target="_blank">Genetic subtyping of obesity reveals biological insights into the uncoupling of adiposity from its cardiometabolic comorbidities</a>  <font color="#6f6f6f">Nature</font>

Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity
PR Newswireworld

Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity

<a href="https://news.google.com/rss/articles/CBMiswJBVV95cUxNekN0ZENkMDdoNTFxMnF6aHVUZ1g4WFJCWUpyTXpKbFp4SjFqeE12SXV2aUtmNkxueHliU0E5LV91aHB0QnFabUNrajhKcnNpQVBDLUR4ZkIycmlTVGNxTDVycnR3c19scTdKbGtvODNxWlJfRnpydklObUZtTFBYMGNXeXg4dDVHVnpLVXpUWVV4RVRsQW1yaFJlbkN2OTBvSEhjcnVKN01WUDk4ZGgxVXJwYjhYb1RpVGlzX1g4SVJ0b1h0dlEzamFEUlNjM1kzSkN0SmZ3LWFCX0lkY285Y0dMSUlzYnhlTGhHbWlhTVRJRjNEM3FtM1dod0FVNGxMdTF4eWVobDFQdjI1MGtGLThzZkRLd3V3Q1pKVm1ZUkxINmtlVXI5aGlfNTNqeWt6TUlF?oc=5" target="_blank">Superluminal Medicines Announces Collaboration with Eli Lilly and Company to Advance Small Molecule Therapeutics for Cardiometabolic Diseases and Obesity</a>  <font color="#6f6f6f">PR Newswire</font>

Editorial: Molecular biomarkers of cardiometabolic disease
Frontiersgeneral

Editorial: Molecular biomarkers of cardiometabolic disease

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQcDM3SmtNaE9mQ1lwZDVXbmo3Ml9GcVp4elhCTHdZRE5OX0QyQ3ZaNzFkZFdxOVJPSFJpYktGaXl5XzdZWW11aGdLNV96YmNzdnVEbHNWYlNORjJGWEVUMHFsNy1qc21IUHFPWXpmUnpOa1RORVBiR0tsQXdFckJYU3NEZ25wbU9VcnVoWGZkaXpVTnc0ZHc?oc=5" target="_blank">Editorial: Molecular biomarkers of cardiometabolic disease</a>  <font color="#6f6f6f">Frontiers</font>

Metabolic crosstalk between differentiated thyroid cancer and cardiovascular disease: insulin resistance as a molecular bridge—a proposed mechanism
Frontiersgeneral

Metabolic crosstalk between differentiated thyroid cancer and cardiovascular disease: insulin resistance as a molecular bridge—a proposed mechanism

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOYVdpQzFUUktrVzZsdEQ2X2JaWXFub2swZk95ZjRaamFxemtJVlBET0dEZTNrSkZndmd5ZzUzczdKbVFsN1NpRXphQTN5Ym5jcXFsSGV2M0NSUVdOd3hoczZSR3RHV2N1cUREdnRQOF9BVy1ZdWlMaHQyRVBXWmVQQUJEVGlFOVM3bjAzY2k2RkUwbU9zZFE?oc=5" target="_blank">Metabolic crosstalk between differentiated thyroid cancer and cardiovascular disease: insulin resistance as a molecular bridge—a proposed mechanism</a>  <font color="#6f6f6f">Frontiers</font>

Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging
Naturegeneral

Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1wM3l1VWNERjktODZLc2FXb2RxeW96dUN2THRfQzJMaWpaUk4xUzliblVleTljaWZwODNsNWVvcEctZGc0TXkySlJubEJScVFSNnhqM1BtQWlkVkl0RXZj?oc=5" target="_blank">Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging</a>  <font color="#6f6f6f">Nature</font>

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies
Insilico Medicinegeneral

Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPRmtYZ3FyQmJ6WGplejNCTUJ2Q1ktcnc4Sk1TRk5WWGp0STBxUDY0ZFIzMGt6ajJPUmNVcUNkQW9sYmtDb05FZ3FycXhqQXNFVGF1VDJmWHlUa1NkeDZBSVNxaXQ3ZDRpMDVEZVJ5dzV2aFFuNW1HMHFLNjZxR3c4UTZDUQ?oc=5" target="_blank">Insilico Medicine and Qilu Pharmaceutical Reach Near $120 Million Drug Development Collaboration to Accelerate Novel Cardiometabolic Therapies</a>  <font color="#6f6f6f">Insilico Medicine</font>

Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images
Naturegeneral

Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1VVjlpS09KT0hjMkNuZDBtS1l4S2ZtWExjc0c5RGpCVGZHclFMVGUxUE5GTUJzSlN2MWo1VFR2bHR1bXBWV2k4RjdWS0E1Q0FjZ2NCendhU0QwbFVGOUxV?oc=5" target="_blank">Multi-organ network of cardiometabolic disease-depression multimorbidity revealed by phenotypic and genetic analyses of MR images</a>  <font color="#6f6f6f">Nature</font>

Editorial: Oxidative stress and inflammation in cardiometabolic disorders
Frontiersgeneral

Editorial: Oxidative stress and inflammation in cardiometabolic disorders

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQNmpQeHNPelZlZXdudFFuNHVOZ0Vfdm1IekZpNWp5c19oaTd0WmJHeU5IVWI4YnduQ0IyWlE0eXU4d2pMTlhOTmRyaFBiNVIxdGJoVG1kX0tiY3NSNUhoNXByb2lVODdEYzFBVHQ2R1VqZ291ZEowaDZOTEtKMno5OURHb2pRWjN5NnQtX3dYQVVvWXpwREE?oc=5" target="_blank">Editorial: Oxidative stress and inflammation in cardiometabolic disorders</a>  <font color="#6f6f6f">Frontiers</font>

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets
Naturescience

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9aenBPaXpSMmZQektnejhZd0FBVnNMME1kOEVmazZ4dnVzZ0c0eWhza2o0cmpvX2NiOG9RQkZqQ2owNzV5U3RKY1pxelRvU2JVcG4wOHRNS0lkSTBGX0Vz?oc=5" target="_blank">Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets</a>  <font color="#6f6f6f">Nature</font>

From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health
Frontiersscience

From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxPbks1NlNjM3RVeTNjNEhFeDdfWDJCWHoxUUVLNzllWkJGaTRiTjNRYVVNSS1xLTNSeFZyLVNoUGhkX0Z5RHJqSW56NXoyVGVZdnpGeFlJUmtsNGhfLWptOVgwUTdKZ3oydkp0bm9rVmMwUW4wUHVraUVXckpjZ3NSY29oSnpYeWh6ZEljV1FjN3BCUzhncEFya0FxdjJRdlNPQXc?oc=5" target="_blank">From meal to malfunction: exploring molecular pathways, biomarkers and interventions in postprandial cardiometabolic health</a>  <font color="#6f6f6f">Frontiers</font>

Molecular transducers and the cardiometabolic benefits of exercise
Naturegeneral

Molecular transducers and the cardiometabolic benefits of exercise

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE0yOFEwWFpTYUxCMmZhYU9uY2N4YzVIekdvU1NtcFFpeElwelhGN1RxMnFHVXVfb19YYm13dmpManI4RHNvYnhhWjZpSnJQWjJvRk5fTl9YcEo3c09nN0Rz?oc=5" target="_blank">Molecular transducers and the cardiometabolic benefits of exercise</a>  <font color="#6f6f6f">Nature</font>

Molecular lipid architecture emerges as a new frontier in omega-3 nutrition
Nutraceutical Business Reviewgeneral

Molecular lipid architecture emerges as a new frontier in omega-3 nutrition

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOTU4xbXNDeERMWVV2R29BdDhmTFJDVzhaMHJranc3aVhfZUN4YldLTUZsYWt5aEkwQ0dLOWhFLTh2dXBZTFdiQURUUVhSU3ctWW05X0huN3ROWHU3UlpPRW1FVld6cDlMYWpsOTJ4UkVTU3BaWTg1SlJYMS1VLWc4UmEzTG9qRVA4LTRScjMxdXNyckJVUzJITV9B?oc=5" target="_blank">Molecular lipid architecture emerges as a new frontier in omega-3 nutrition</a>  <font color="#6f6f6f">Nutraceutical Business Review</font>

Up to 31.3% Body Weight Loss, Insilico Medicine Nominates AI-Powered GIPR Antagonist ISM0676 as Preclinical Candidate, Showing Synergistic Efficacy in Combination Therapy
Insilico Medicinetech

Up to 31.3% Body Weight Loss, Insilico Medicine Nominates AI-Powered GIPR Antagonist ISM0676 as Preclinical Candidate, Showing Synergistic Efficacy in Combination Therapy

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxPOVdRZ2tsSHF3MFBaYnVRaWVfTUI1SFpmNWJkVDc4V09XaTR2THdsdmZmdXBaVVVqdUFQUWtHV1kxR1M4ZDlBT0lzR2ZkbUdhQmRIdURGQnZnMDV6aUhxejkzS1hZRWNVc3cwWF9wOFVtdGtaZi1zVUpkeDRoMk0yWXBDVQ?oc=5" target="_blank">Up to 31.3% Body Weight Loss, Insilico Medicine Nominates AI-Powered GIPR Antagonist ISM0676 as Preclinical Candidate, Showing Synergistic Efficacy in Combination Therapy</a>  <font color="#6f6f6f">Insilico Medicine</font>

Genetic clues in 3,000 Indians reveal new lipid routes to cardiometabolic disease
Medical Xpressgeneral

Genetic clues in 3,000 Indians reveal new lipid routes to cardiometabolic disease

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxQYnNUZlRZdWVyRm9xRmxfZlotY1RjbjhKS09KY2E1WU56TGx3OGhIZDNBbVZfTkVacmtTZ0pJUUtCNU41TElqaWFtYWNzVDJYb0xuanVQZEVJamwzTnk2UzF2VHJ4OXp6a21aWXQyVGhJMW5STHJFNDJzLWVMWHJvTXVublg?oc=5" target="_blank">Genetic clues in 3,000 Indians reveal new lipid routes to cardiometabolic disease</a>  <font color="#6f6f6f">Medical Xpress</font>

Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
BioSpacegeneral

Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNZFZIQnpEZ01VZ0lwUlpETW5yc05ZUkxjRks5eWl0ZW1MZWtsdzRDSGd0U3Z2bGM1RExDY2dMSVQxdUpKOUZCOHgtbXVnVHJwY3pINDZ2SHhTQkswQS16eE81ZzRqWE4yZzgyaElqV2VFcHU0UExHbjc2RHlMNWluZ3MtdFRzSV9Pdzh2VTNmNTNwRjJrZ0VyNDZ0WjJiSkRQSGc?oc=5" target="_blank">Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs</a>  <font color="#6f6f6f">BioSpace</font>

"Cardiometabolic and molec" — Live Google News Trends & Headlines